MYCN gene amplification is a powerful prognostic factor even in infantile neuroblastoma detected by mass screening.
Iehara T, Hosoi H, Akazawa K, Matsumoto Y, Yamamoto K, Suita S, Tajiri T, Kusafuka T, Hiyama E, Kaneko M, Sasaki F, Sugimoto T, Sawada T.
Iehara T, et al. Among authors: hosoi h.
Br J Cancer. 2006 May 22;94(10):1510-5. doi: 10.1038/sj.bjc.6603149.
Br J Cancer. 2006.
PMID: 16670717
Free PMC article.